| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CNS Pharmaceuticals, Inc. | CEO and President, Director | Restricted Stock Units | 19,000 | 01 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CNSP | CNS Pharmaceuticals, Inc. | 01 Jan 2026 | 1 | $0 | 4 | CEO and President, Director | 02 Jan 2026, 17:01 |
| CNSP | CNS Pharmaceuticals, Inc. | 01 Jan 2026 | 0 | $0 | 3 | CEO and President, Director | 02 Jan 2026, 17:00 |